AE, M., AH, G., S, S., J, T., M, A., AS, R., . . . AS, D. G. (2024). In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies. MAbs, 16(1), 2333729. https://doi.org/10.1080/19420862.2024.2333729
Chicago Style (17th ed.) CitationAE, Mattei, Gutierrez AH, Seshadri S, Tivin J, Ardito M, Rosenberg AS, Martin WD, and De Groot AS. "In Silico Methods for Immunogenicity Risk Assessment and Human Homology Screening for Therapeutic Antibodies." MAbs 16, no. 1 (2024): 2333729. https://doi.org/10.1080/19420862.2024.2333729.
MLA (9th ed.) CitationAE, Mattei, et al. "In Silico Methods for Immunogenicity Risk Assessment and Human Homology Screening for Therapeutic Antibodies." MAbs, vol. 16, no. 1, 2024, p. 2333729, https://doi.org/10.1080/19420862.2024.2333729.